Migraine drugmaker Alder Biopharmaceuticals to be acquired for nearly $2B by Lundbeck Danish drugmaker Lundbeck is set to buy Bothell, Wash.-based Alder Biopharmaceuticals in a deal that could be worth up to… Read More
